このページの翻訳は実験的なもので、現在開発中です。フィードバックを お待ちしております！
RTALB 株式概要 RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. 競合他社 価格と性能
の歴代最高値、変動、値下がりまとめRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret 過去の株価 現在の株価 ₺11.78 52週高値 ₺21.20 52週安値 ₺8.37 ベータ 0.11 11ヶ月の変化 3.88% 3ヶ月変化 1.46% 1年変化 38.92% 33年間の変化 37.21% 5年間の変化 1,961.24% IPOからの変化 798.83%
最新ニュース
First quarter 2024 earnings released Jun 13
Now 21% undervalued after recent price drop May 24
New minor risk - Financial data availability May 17
Now 21% undervalued after recent price drop May 07
Now 21% undervalued after recent price drop Mar 13
Investor sentiment improves as stock rises 22% Dec 05 最新情報をもっと見る
First quarter 2024 earnings released Jun 13
Now 21% undervalued after recent price drop May 24
New minor risk - Financial data availability May 17
Now 21% undervalued after recent price drop May 07
Now 21% undervalued after recent price drop Mar 13
Investor sentiment improves as stock rises 22% Dec 05
Investor sentiment deteriorates as stock falls 16% Oct 12
Investor sentiment improves as stock rises 16% Sep 11
Investor sentiment improves as stock rises 20% Aug 16
Second quarter 2023 earnings released Aug 14
Investor sentiment improves as stock rises 17% Jun 01
Full year 2022 earnings released Mar 16
Investor sentiment improves as stock rises 17% Mar 09
Investor sentiment deteriorates as stock falls 18% Feb 01
Investor sentiment deteriorated over the past week Jan 05
Investor sentiment improved over the past week Nov 28
Insufficient new directors Nov 16
Investor sentiment improved over the past week Oct 10
Second quarter 2022 earnings released: EPS: ₺0.59 (vs ₺0.39 in 2Q 2021) Aug 21
Investor sentiment improved over the past week Jul 15
Investor sentiment improved over the past week Jun 30
Investor sentiment improved over the past week Jun 15
First quarter 2022 earnings released: EPS: ₺0.78 (vs ₺0.60 in 1Q 2021) May 12
Insufficient new directors Apr 27
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 13
Investor sentiment deteriorated over the past week Feb 24
Investor sentiment improved over the past week Nov 30
Third quarter 2021 earnings released Nov 12
Investor sentiment improved over the past week Sep 08
Second quarter 2021 earnings released Aug 24
First quarter 2021 earnings released: EPS ₺0.60 (vs ₺0.24 in 1Q 2020) Jun 12
Investor sentiment deteriorated over the past week Apr 17
Investor sentiment improved over the past week Mar 29
Full year 2020 earnings released: EPS ₺1.49 (vs ₺0.15 in FY 2019) Mar 13
Investor sentiment deteriorated over the past week Feb 23
New 90-day low: ₺25.66 Feb 19
New 90-day low: ₺28.08 Jan 18
New 90-day low: ₺33.08 Dec 24
Investor sentiment deteriorated over the past week Dec 16
New 90-day low: ₺40.28 Dec 07
Third quarter 2020 earnings released: EPS ₺0.34 Nov 08
Market bids up stock over the past week Oct 29
New 90-day high - ₺59.20 Aug 25
First half earnings released Aug 14
New 90-day high - ₺51.85 Aug 07 株主還元 RTALB TR Biotechs TR 市場 7D -3.5% -1.4% -1.5% 1Y 38.9% -15.5% 97.6%
株主還元を見る
業界別リターン: RTALB過去 1 年間で-15.8 % の収益を上げたTR Biotechs業界を上回りました。
リターン対市場: RTALBは、過去 1 年間で113.5 % のリターンを上げたTR市場を下回りました。
価格変動 Is RTALB's price volatile compared to industry and market? RTALB volatility RTALB Average Weekly Movement 6.7% Biotechs Industry Average Movement 6.8% Market Average Movement 7.3% 10% most volatile stocks in TR Market 10.6% 10% least volatile stocks in TR Market 5.2%
安定した株価: RTALB過去 3 か月間に大きな価格変動はありませんでした。
時間の経過による変動: RTALBの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。
会社概要 RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.はトルコで微生物学と分子生物学製品の研究、開発、生産に従事している。シャーレ、チューブ、ボトル、発色培地、血液培養ボトル、結核診断、迅速検査、微生物染色、ハイギスライド、サーチェック培地、メンブレン、スワブ製品などの微生物学製品、核酸分離キット、リアルタイムPCRキット、ボルトランウイルス量検出システムなどの分子生物学製品を提供。同社は1996年に法人化され、トルコのコチェリに拠点を置く。
もっと見る RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. 基礎のまとめ RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret の収益と売上を時価総額と比較するとどうか。 RTALB 基礎統計学 時価総額 ₺1.18b 収益（TTM） ₺119.43m 売上高(TTM ) ₺100.21m
収益と収入 最新の決算報告書（TTM）に基づく主な収益性統計 RTALB 損益計算書（TTM） 収益 ₺100.21m 売上原価 ₺82.68m 売上総利益 ₺17.53m その他の費用 -₺101.90m 収益 ₺119.43m
一株当たり利益（EPS） 1.19 グロス・マージン 17.49% 純利益率 119.19% 有利子負債／自己資本比率 1.1%
RTALB の長期的なパフォーマンスは？
過去の実績と比較を見る
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
